Jackson Creek Investment Advisors LLC Intra Cellular Therapies, Inc. Transaction History

Jackson Creek Investment Advisors LLC

  • $338 Million
  • Q3 2024

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 05, 2024
SELL
$46.37 - $73.65 $278 - $441
-6 Reduced 0.04%
14,125 $1.01 Million
Q3 2023

Nov 03, 2023
SELL
$52.09 - $64.1 $416 - $512
-8 Reduced 0.06%
14,131 $736,000
Q2 2023

Aug 02, 2023
BUY
$54.67 - $66.44 $772,979 - $939,395
14,139 New
14,139 $895,000
Q4 2022

Feb 03, 2023
BUY
$44.07 - $54.45 $732,178 - $904,632
16,614 New
16,614 $879,000
Q2 2022

Aug 04, 2022
BUY
$43.0 - $65.64 $737,149 - $1.13 Million
17,143 New
17,143 $928,000

Others Institutions Holding ITCI

# of Institutions
378
Shares Held
84.7M
Call Options Held
319K
Put Options Held
143K
View Full List

About Intra-Cellular Therapies, Inc.

ITCI Quotes by TradingView
  • Ticker ITCI
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 94,401,696
  • Market Cap $7.85B
  • Description
  • Intra-Cellular Therapies, Inc., a biopharmaceutical company, develops novel drugs for the treatment of neuropsychiatric and neurologic diseases by targeting intracellular signaling mechanisms within the central nervous system in the United States. The company offers CAPLYTA for the treatment of schizophrenia in adults. It is also involved in dev...
More about ITCI
Track This Portfolio

Track Jackson Creek Investment Advisors LLC Portfolio

Follow Jackson Creek Investment Advisors LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Jackson Creek Investment Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Jackson Creek Investment Advisors LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email